Ionis Pharmaceuticals, Inc. SEC filings IONS

Ionis Pharmaceuticals, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Jul 6, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 29, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Ionis Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 21, 2026 Oct 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 4, 2026 Sep 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 4, 2026 Sep 3, 2026
S-8 Employee stock plan registration Jul 31, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Regulation FD disclosure
Jul 10, 2026 Jul 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2026 Jul 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 24, 2026 Jun 24, 2026
8-K Current report
Other events
Jun 12, 2026 Jun 12, 2026
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Jun 8, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure, Other events
May 28, 2026 May 28, 2026
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 21, 2026 Apr 21, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 9, 2026 Mar 3, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2026 Jan 7, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 17, 2025 Nov 11, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 10, 2025 Nov 8, 2025
8-K/A Amended current report
Material agreement
Nov 3, 2025 Oct 28, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 22, 2025 Sep 22, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 2, 2025 Sep 2, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 21, 2025 Aug 21, 2025
S-8 Employee stock plan registration Jul 30, 2025 —
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
8-K Current report
Officer or director change
Jun 12, 2025 Jun 12, 2025
8-K Current report
Shareholder vote results
Jun 10, 2025 Jun 5, 2025
8-K Current report
Other events
May 19, 2025 May 19, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 5, 2025
8-K Current report
Material agreement
Mar 12, 2025 Mar 11, 2025
10-K Annual report Feb 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 19, 2025 Feb 19, 2025
8-K Current report
Other events
Dec 20, 2024 Dec 19, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Other events
Sep 12, 2024 Sep 9, 2024
424B5 Prospectus supplement Sep 10, 2024 —
8-K Current report
Other events
Sep 9, 2024 Sep 9, 2024
424B5 Prospectus supplement Sep 9, 2024 —
S-8 Employee stock plan registration Aug 5, 2024 —
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Material agreement
Jun 18, 2024 Jun 18, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
8-K Current report
Other events
May 31, 2024 May 31, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 6, 2024
8-K Current report
Other events
Apr 8, 2024 Apr 7, 2024
8-K Current report
Material agreement, Officer or director change
Feb 29, 2024 Feb 28, 2024
10-K Annual report Feb 21, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 21, 2024 Feb 21, 2024
8-K Current report
Other events
Jan 22, 2024 Jan 22, 2024
8-K Current report
Other events
Dec 22, 2023 Dec 21, 2023
8-K Current report
Material agreement
Dec 18, 2023 Dec 18, 2023
8-K Current report
Officer or director change
Dec 14, 2023 Dec 14, 2023
S-3ASR Automatic shelf registration Nov 24, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Material agreement
Sep 27, 2023 Sep 27, 2023
8-K Current report
Other events
Sep 26, 2023 Sep 26, 2023
8-K Current report
Other events
Aug 23, 2023 Aug 21, 2023
8-K Current report
Other events
Aug 22, 2023 Aug 21, 2023
S-8 Employee stock plan registration Aug 11, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Agreement ended
Aug 4, 2023 Aug 1, 2023
8-K Current report
Material agreement
Aug 3, 2023 Aug 2, 2023
8-K Current report
Other events
Jul 10, 2023 Jul 10, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 12, 2023 Jun 8, 2023
8-K Current report
Other events
Jun 6, 2023 Jun 6, 2023
8-K Current report
Shareholder vote results
Jun 5, 2023 Jun 1, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
8-K Current report
Other events
Apr 26, 2023 Apr 25, 2023
8-K Current report
Other events
Apr 24, 2023 Apr 24, 2023
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 —
8-K Current report
Other events
Mar 27, 2023 Mar 27, 2023
10-K Annual report Feb 22, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
8-K Current report
Material agreement
Jan 9, 2023 Jan 8, 2023
8-K Current report
Material agreement, Results of operations
Nov 14, 2022 Nov 10, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Agreement ended
Nov 4, 2022 Oct 31, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, New debt
Oct 24, 2022 Oct 20, 2022
8-K Current report
Material agreement
Oct 12, 2022 Oct 6, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Listing notice
Jul 28, 2022 Jul 22, 2022
8-K Current report
Other events
Jul 19, 2022 Jul 18, 2022
8-K Current report
Officer or director change
Jul 18, 2022 Jul 15, 2022
8-K Current report
Material agreement
Jul 11, 2022 Jul 11, 2022
8-K Current report
Other events
Jun 21, 2022 Jun 21, 2022
8-K Current report
Shareholder vote results
Jun 6, 2022 Jun 2, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 20, 2022 —
DEF 14A Proxy statement Apr 20, 2022 Jun 2, 2022
8-K Current report
Officer or director change
Mar 21, 2022 Mar 17, 2022
10-K Annual report Feb 25, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Agreement ended
Jan 31, 2022 Jan 24, 2022
8-K Current report
Material agreement
Dec 7, 2021 Dec 6, 2021
8-K Current report
Officer or director change
Nov 26, 2021 Nov 26, 2021
8-K Current report
Other events
Nov 24, 2021 Nov 24, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
8-K Current report
Other events
Oct 18, 2021 Oct 17, 2021
S-8 Employee stock plan registration Aug 5, 2021 —
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2021 Jun 2, 2021
DEFA14A Additional proxy material May 20, 2021 —
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 2, 2021
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Apr 13, 2021 Apr 6, 2021
8-K Current report
Exit or restructuring costs
Apr 6, 2021 Apr 6, 2021
8-K Current report
Bylaw or fiscal year change
Mar 29, 2021 Mar 26, 2021
8-K Current report
Other events
Mar 23, 2021 Mar 22, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
UPLOAD Letter from the SEC Jan 26, 2021 —
CORRESP Letter to the SEC Jan 14, 2021 —
S-8 Employee stock plan registration Dec 31, 2020 —
UPLOAD Letter from the SEC Dec 30, 2020 —
8-K Current report
Material agreement, Officer or director change
Dec 18, 2020 Dec 17, 2020
8-K Current report
Other events
Dec 9, 2020 Dec 8, 2020
CT ORDER Filing Dec 3, 2020 —
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Acquisition or sale of assets, Other events
Oct 13, 2020 Oct 10, 2020
SC TO-T/A Filing Oct 13, 2020 —
SC TO-T/A Filing Oct 2, 2020 —
SC TO-T/A Filing Sep 30, 2020 —
SC TO-T/A Filing Sep 29, 2020 —
SC TO-T/A Filing Sep 24, 2020 —
CORRESP Letter to the SEC Sep 24, 2020 —
SC TO-T Filing Sep 14, 2020 —
SC TO-C Filing Sep 1, 2020 —
SC TO-C Filing Aug 31, 2020 —
SC TO-C Filing Aug 31, 2020 —
8-K Current report
Material agreement, Other events
Aug 31, 2020 Aug 30, 2020
S-8 Employee stock plan registration Aug 7, 2020 —
S-3ASR Automatic shelf registration Aug 7, 2020 —
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020

Showing 168 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IONS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
Carlsbad, CA
SEC filer status
Large accelerated filer
SEC CIK
874015
Former names
ISIS PHARMACEUTICALS INC (until Dec 18, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.